Evidence map›Paper›PMID 27640198›Full record

ArticleJournal of neuro-oncology2017

Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.

Yuelong Wang, Jiaojiao Deng, Gang Guo, Aiping Tong, Xirui Peng, Haifeng Chen, Jianguo Xu, Yi Liu, Chao You, Liangxue Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yuelong WangWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Jiaojiao DengWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Gang GuoState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China.
Aiping TongState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China. aipingtong@scu.edu.cn.
Xirui PengState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China.
Haifeng ChenWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Jianguo XuWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Yi LiuWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Chao YouWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Liangxue ZhouWest China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China. liangxue_zhou@126.com.
West China Medical Center of Sichuan University · CNState Key Laboratory of BiotherapySichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annexin A2 (AnxA2) is a highly conserved Ca2

Indexed as

AdolescentAdultAgedAnnexin A2Antineoplastic AgentsBrainCell MovementCell ProliferationChildChild, PreschoolCohort StudiesCraniopharyngiomaErbB ReceptorsFemaleGefitinibGene Expression Regulation, NeoplasticAnnexin A2Antineoplastic AgentsEGFR protein, humanErbB ReceptorsGefitinibOncogene Protein v-aktQuinazolinesAdamantinomatous craniopharyngiomaAnnexin A2Gefitinib resistanceProliferationRecurrence

Identifiers

PMID27640198
OpenAlexW2520062967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.